Table 2.
Seropositivity against four different antigens in study population
| Category | PfMSP1-19 | PvMSP1-9 | PvAMA1 | PvDBPII | ||||
|---|---|---|---|---|---|---|---|---|
| n (%) | p | n (%) | p | n (%) | p | n (%) | p | |
| Age (year) | ||||||||
| < 15 | 18 (30.0) | 0.000 | 45 (12.0) | 0.599 | 43 (28.7) | 0.062 | 77 (51.3) | 0.004 |
| > 15 | 55 (33.3) | 40 (45.8) | 22 (18.3) | 83 (69.2) | ||||
| Sex | ||||||||
| Male | 40 (29.6) | 0.411 | 36 (26.7) | 0.116 | 34 (25.2) | 0.776 | 73 (54.1) | 0.107 |
| Female | 33 (24.4) | 49 (36.3) | 31 (23.0) | 87 (64.4) | ||||
| History of malaria within 3 years | ||||||||
| Yes | 40 (32.2) | 0.025 | 46 (37.1) | 0.098 | 27 (21.8) | 0.710 | 75 (60.5) | 0.171 |
| No | 31 (26.3) | 29 (24.6) | 31 (26.3) | 73 (61.9) | ||||
| Not sure | 2 (7.1) | 10 (35.7) | 7 (25.0) | 12 (42.9) | ||||